BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33104018)

  • 21. Estimation of prognostic value of Bcl-xL gene expression in non-small cell lung cancer.
    Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Korobowicz E; Korszen-Pilecka I; Zdunek M
    Lung Cancer; 2006 Jan; 51(1):61-9. PubMed ID: 16297499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of CD44s expression in resected non-small cell lung cancer.
    Ko YH; Won HS; Jeon EK; Hong SH; Roh SY; Hong YS; Byun JH; Jung CK; Kang JH
    BMC Cancer; 2011 Aug; 11():340. PubMed ID: 21819617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer.
    Cao X; Chen YZ; Luo RZ; Zhang L; Zhang SL; Zeng J; Jiang YC; Han YJ; Wen ZS
    Oncotarget; 2015 May; 6(13):11704-13. PubMed ID: 25868976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of ARID1A expression is associated with poor prognosis in non-small cell lung cancer.
    Jang SH; Lee JH; Lee HJ; Cho H; Ahn H; Song IH; Oh MH
    Pathol Res Pract; 2020 Nov; 216(11):153156. PubMed ID: 32823232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive expression of pro-opiomelanocortin (POMC) is a novel independent poor prognostic marker in surgically resected non-small cell lung cancer.
    Hao L; Zhao X; Zhang B; Li C; Wang C
    Tumour Biol; 2015 Mar; 36(3):1811-7. PubMed ID: 25377161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancer.
    Cox G; Louise Jones J; Andi A; Abrams KR; O'Byrne KJ
    Lung Cancer; 2001 Dec; 34(3):417-26. PubMed ID: 11714539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients.
    Han F; Zhang MQ; Liu WB; Sun L; Hao XL; Yin L; Jiang X; Cao J; Liu JY
    Respir Res; 2018 Dec; 19(1):241. PubMed ID: 30514297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients.
    Ferreira CG; van der Valk P; Span SW; Ludwig I; Smit EF; Kruyt FA; Pinedo HM; van Tinteren H; Giaccone G
    Clin Cancer Res; 2001 Aug; 7(8):2468-74. PubMed ID: 11489828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective study.
    Zhang L; Hou X; Lu S; Rao H; Hou J; Luo R; Huang H; Zhao H; Jian H; Chen Z; Liao M; Wang X
    Lung Cancer; 2010 Jan; 67(1):114-9. PubMed ID: 19376608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LRH1 as a promising prognostic biomarker and predictor of metastasis in patients with non-small cell lung cancer.
    Liu Y; Xing Y; Wang H; Yan S; Wang X; Cai L
    Thorac Cancer; 2018 Dec; 9(12):1725-1732. PubMed ID: 30273983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of PD-L1 protein as a prognostic factor in lung squamous cell carcinoma.
    Takada K; Okamoto T; Toyokawa G; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takamori S; Katsura M; Shoji F; Oda Y; Maehara Y
    Lung Cancer; 2017 Feb; 104():7-15. PubMed ID: 28213003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multiple marker analysis of apoptosis-associated protein expression in non-small cell lung cancer in a Chinese population.
    Fan CF; Xu HT; Lin XY; Yu JH; Wang EH
    Folia Histochem Cytobiol; 2011; 49(2):231-9. PubMed ID: 21744322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of HSP10 correlates with HSP60 and Mcl-1 levels and predicts poor prognosis in non-small cell lung cancer patients.
    Tang Y; Yang Y; Luo J; Liu S; Zhan Y; Zang H; Zheng H; Zhang Y; Feng J; Fan S; Wen Q
    Cancer Biomark; 2021; 30(1):85-94. PubMed ID: 32986659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary tumor standardized uptake value (SUVmax) measured on
    Hui Z; Wei F; Ren H; Xu W; Ren X
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2595-2605. PubMed ID: 32494919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signaling protein signature predicts clinical outcome of non-small-cell lung cancer.
    Jin BF; Yang F; Ying XM; Gong L; Hu SF; Zhao Q; Liao YD; Chen KZ; Li T; Tai YH; Cao Y; Li X; Huang Y; Zhan XY; Qin XH; Wu J; Chen S; Guo SS; Zhang YC; Chen J; Shen DH; Sun KK; Chen L; Li WH; Li AL; Wang N; Xia Q; Wang J; Zhou T
    BMC Cancer; 2018 Mar; 18(1):259. PubMed ID: 29510676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Keratin 34betaE12/keratin7 expression is a prognostic factor of cancer-specific and overall survival in patients with early stage non-small cell lung cancer.
    Pøhl M; Olsen KE; Holst R; Donnem T; Busund LT; Bremnes RM; Al-Saad S; Andersen S; Richardsen E; Ditzel HJ; Hansen O
    Acta Oncol; 2016; 55(2):167-77. PubMed ID: 26057535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic role of liver X receptor-alpha in resected stage II and III non-small-cell lung cancer.
    Melloni G; Muriana P; Bandiera A; Fontana R; Maggioni D; Russo V; Doglioni C; Zannini P
    Clin Respir J; 2018 Jan; 12(1):241-246. PubMed ID: 27401614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic role of Bcl-2 mRNA expression in curatively resected non-small cell lung cancer (NSCLC).
    Grimminger PP; Schneider PM; Metzger R; Vallböhmer D; Danenberg KD; Danenberg PV; Hölscher AH; Brabender J
    Lung Cancer; 2010 Oct; 70(1):82-7. PubMed ID: 20064672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients.
    Ludovini V; Bellezza G; Pistola L; Bianconi F; Di Carlo L; Sidoni A; Semeraro A; Del Sordo R; Tofanetti FR; Mameli MG; Daddi G; Cavaliere A; Tonato M; Crinò L
    Ann Oncol; 2009 May; 20(5):842-9. PubMed ID: 19153117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.